Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - TOTAL CURRENT LIABILITIES
Total Current Liabilities TARS - Tarsus Pharmaceuticals, Inc.
36.9 M
LAST VALUE
79.39%
2 YEAR CAGR
190.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR